Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-069-1 | CAS number: 77-92-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
There are no reliable 28-day or 90-day studies available, so this endpoint is waived. Numerous studies have been reported in the literature and are discussed below. The most reliable studies are 10-day studies in rats and mice, with the following results:
NOAEL (10 d) 4000 mg/kg bw/day rats (unidentified gender)
LD50 (10 d) 5660 (+/- 0.44) mg/kg bw/day rats (unidentified gender)
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
There are numerous repeat dose studies that have been conducted. Although they do not meet current testing requirements, they still indicate a lack of any significant toxicological effects under the test conditions that were used. A reliable five-day feeding study in rats gave a NOAEL value of 4000 mg/kg (Bachtold, 1976a); and a 10-day feeding study in mice and rats gave NOAEL (mortality) values of 1000 mg/kg and 4000 mg/kg respectively (Bachtold, 1978a).
Additionally, there are a number of published studies using mice, rabbits, dogs, guinea pigs and pigs with various doses of citric acid or sodium citrate and various dosing periods. Most of the studies report no adverse effects, although some effects that were mentioned are reduced zinc levels, increased zinc excretion and erosion of the tooth enamel: effects attributable to zinc and calcium complexation. Very high doses (5%) of citric acid in the diet administered to male albino mice throughout most of their lives were shown to depress the mean body weight at 14 months by 9.9% (sexually immature animals) and 18.7% (sexually mature animals). This treatment also reduced the mean survival time from 16.7 to 12.7 months and from 16.4 to 10.8 months respectively in the same two groups (Wright and Hughes, 1976b).
A shorter timescale (60 day) feeding study with 5% citric acid in the diet of guinea pigs and rats by the same authors showed no such effect on body weight (Wright and Hughes, 1976a). It was estimated that the dietary uptake of citric acid in both rat and guinea pig studies was 3000 mg/kg/d. There was no increase in tissue concentrations of citric acid, indicating a very efficient homeostasis mechanism due to its rapid metabolism, neither was there any effect on serum alkaline phosphatase: an indicator of tissue damage and specifically liver damage.
In a feeding study in rats, daily oral administration of 1.2, 2.4 and 4.8 % fermentation citric acid in the diet for 6 weeks produced no physiological or behavioural abnormalities, except a slight depression of body weight gain and daily food-intake. Morphological and biochemical examinations of the blood and urine demonstrated mild abnormal findings; however, many of the findings could not be ascribed to the toxic effect of citric acid (Silverstein et al. 1989).
Citric acid plays a central role in cellular metabolism, is naturally present in common fruit and vegetables, which means there is a long history of human exposure; it has been estimated that maximum daily intake of citric acid can reach up to 500 mg/kg/day (OECD SIDS 2001). In addition, citric acid has well established and documented metabolic pathways in humans (JECFA, 1973). It is also added to processed food and beverages, (HERA, 2005); it is a permitted EU Food Additive and, according to the JECFA (Joint Expert Committee on Food Additives of the WHO/ FAO), these products may be used without limitation, according to Good Manufacturing Practice (JECFA, summary of evaluations, citric acid, 1973). The US Food and Drug Administration also classifies citric acid as GRAS (Generally Recognized as Safe) food ingredients (www.accessdata.fda.gov, 2018).
No repeat dose dermal or inhalation animal studies related to citric acid were located. This is probably because citric acid is commonly used as a food additive and therefore the oral route is the most significant (and therefore studied) route of exposure. Similarly, the low vapour pressure of citric acid means that it is unlikely to be inhaled unless used in a spray, or in a powder form containing particles of a respirable size.
Public and private usage of the liquid form indicates that exposure by the dermal route would be the most significant. However, based on the chemical structure of citric acid (hydrophilic, ionisable), it is unlikely that citric acid would penetrate the stratum corneum of the skin. If it did, two sub-cutaneous toxicity studies (Yokotani 1971) indicate a low toxicity (>2500 mg/kg bw).
In humans, the most common adverse effects of taking large doses of citric acid or citrate salts are mild gastrointestinal symptoms (diarrhoea, indigestion and nausea) such as reported in a study in which potassium citrate was administered as a treatment for kidney stones (Pak 1987). However, doses of up to 15 g/d of potassium or sodium citrate have been reported as producing no adverse effects (JECFA, 1974).
Humans have been historically exposed to citric acid and it has been estimated that maximum daily intake of citric acid can reach up to 500 mg/kg/day. (OECD SIDS, 2001).
References
HERA (2005). Human & Environmental Risk Assessment on Ingredients of Household Cleaning Products. Guidance Document Methodology.
JECFA, 1973. Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents. WHO FOOD ADDITIVES SERIES NO. 5. CITRIC ACID AND ITS CALCIUM, POTASSIUM AND SODIUM SALTS. http://www.inchem.org/documents/jecfa/jecmono/v05je24.htmJ
ECFA (1974). Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Food Additives Series No. 5.
Kim, H. M., Shim, I. S., Baek, Y. W., Han, H. J., Kim, P. J., & Choi, K. (2013). Investigation of disinfectants for foot-and-mouth disease in the Republic of Korea. Journal of infection and public health, 6(5), 331-338.
OECD SIDS (2001). SIDS Initial Assessment Report for 11th SIAM (Orlando, Fla., January 2001), for CAS 77-92-9, Citric acid.
Pak, CYC (1987). Citrate and Renal Calculi Mineral Electrolyte Metab. 13, 257-266.
Wright, E., Hughes, R.E., (1976a). Some Effects of Dietary Citric Acid in Small Animals Food and Cosmetics Toxicology 14, 561-564.
Wright and Hughes (1976b). The influence of a dietary citric acid supplement on the reproduction and survival time of mice and rats (publication), Nutr. Rep. Int. 13: 563,. Report date:
Justification for classification or non-classification
Based on the available supporting data, the long history of safe use in food and cosmetics, and the central role played by citric acid in metabolism, no classification is required according Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)